Konstantin Gugleta
Overview
Explore the profile of Konstantin Gugleta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
423
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chatzimichail E, Steinemann-Inauen A, Gugleta K, Feltgen N, Gatzioufas Z
Klin Monbl Augenheilkd
. 2025 Feb;
PMID: 40015306
No abstract available.
2.
Grobshauser E, Cunha Vaz Martinho A, Gatzioufas Z, Hasler P, Maloca P, Gugleta K
Klin Monbl Augenheilkd
. 2025 Jan;
PMID: 39870090
Background: Loss of corneal endothelial cells after glaucoma surgery can lead to corneal decompensation and reduced vision. This loss may be accelerated by drainage implants like PreserFlo, which allow controlled...
3.
Frohlich J, Cattaneo M, Valmaggia P, Maloca P, Gugleta K, Schmetterer L, et al.
Transl Vis Sci Technol
. 2024 Nov;
13(11):8.
PMID: 39514217
Purpose: To study the ocular and systemic factors affecting optic nerve head (ONH) perfusion data as obtained using a commercially available laser speckle flowgraphy (LSFG) device in a cohort of...
4.
Dervos T, Fortuna L, Gugleta K, Scholl H, Gatzioufas Z, Hasler P, et al.
Heliyon
. 2024 Sep;
10(16):e36019.
PMID: 39224325
Purpose: To investigate the clinical outcomes of micropulse transscleral laser therapy (MP-TLT) in a cohort of glaucoma patients, including safety profile, post-operative transient intraocular pressure (IOP) spikes, long-term efficacy and...
5.
Grosso A, Ceruti P, Garlasco J, Frohlich J, Orione M, Gugleta K, et al.
Int Ophthalmol
. 2024 Jun;
44(1):243.
PMID: 38904834
Purpose: To describe the outcomes of double implantation of Xen 45 Gel Stent (Xen) using an ab externo approach with closed conjunctiva. Methods: Retrospective single-centre case series of primary open-angle...
6.
van Eijgen J, Schuhmann V, Fingerroos E, Renier M, Burchert H, Kropfl J, et al.
Front Physiol
. 2024 May;
15:1349313.
PMID: 38818519
Background: Glaucoma stands as a prominent global cause of irreversible blindness and the primary treatment approach involves reducing intraocular pressure (IOP). However, around one-third of patients exhibit disease progression despite...
7.
Martinho A, Chatzimichail E, Gugleta K, Gatzioufas Z
Klin Monbl Augenheilkd
. 2024 Apr;
241(4):385-387.
PMID: 38653267
No abstract available.
8.
Chatzimichail E, Martinho A, Pfau K, Gugleta K, Gatzioufas Z
Klin Monbl Augenheilkd
. 2024 Apr;
241(4):381-384.
PMID: 38653266
No abstract available.
9.
Papazoglou A, Hohn R, Schawkat M, Tappeiner C, Iliev M, Gugleta K, et al.
Ophthalmol Ther
. 2024 Apr;
13(6):1513-1525.
PMID: 38581605
Introduction: The aim of this study was to investigate the 2-year postoperative efficacy of the XEN45 Gel Stent by evaluating the reduction of intraocular pressure (IOP) and the need for...
10.
Papadopoulou A, Pfister A, Tsagkas C, Gaetano L, Sellathurai S, DSouza M, et al.
Clin Neurophysiol
. 2024 Mar;
161:122-132.
PMID: 38461596
Objective: To explore associations of the main component (P100) of visual evoked potentials (VEP) to pre- and postchiasmatic damage in multiple sclerosis (MS). Methods: 31 patients (median EDSS: 2.5), 13...